FR2186470A1 - Purine nucleoside nitrates - for treating cardiac insufficiency - Google Patents
Purine nucleoside nitrates - for treating cardiac insufficiencyInfo
- Publication number
- FR2186470A1 FR2186470A1 FR7318902A FR7318902A FR2186470A1 FR 2186470 A1 FR2186470 A1 FR 2186470A1 FR 7318902 A FR7318902 A FR 7318902A FR 7318902 A FR7318902 A FR 7318902A FR 2186470 A1 FR2186470 A1 FR 2186470A1
- Authority
- FR
- France
- Prior art keywords
- purine nucleoside
- cardiac insufficiency
- nitrates
- treating cardiac
- prepd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Novel title cpds are of formula (I): (R=NH2 or OH; R1 and R2=H or NO2; R3=NO2) and are prepd by reacting corresp. purine nucleoside with fuming HNO3 opt. mixed with acetic anhydride, pref. at between -70 degrees C and room temp. (I) are useful in treatment of cardiac insufficiency and also in purine nucleoside chemistry since the NO2 gps are relatively stable acids and bases but easily removed by hydrogenolysis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19722226295 DE2226295A1 (en) | 1972-05-30 | 1972-05-30 | NITRIC ACID ESTERS OF PURIN NUCLEOSIDES AND METHOD FOR MANUFACTURING THE SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2186470A1 true FR2186470A1 (en) | 1974-01-11 |
FR2186470B1 FR2186470B1 (en) | 1976-06-11 |
Family
ID=5846334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7318902A Granted FR2186470A1 (en) | 1972-05-30 | 1973-05-24 | Purine nucleoside nitrates - for treating cardiac insufficiency |
Country Status (3)
Country | Link |
---|---|
AT (1) | AT323336B (en) |
DE (1) | DE2226295A1 (en) |
FR (1) | FR2186470A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1758596A2 (en) * | 2004-05-26 | 2007-03-07 | Inotek Pharmaceuticals Corporation | Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
US7732424B2 (en) | 2005-11-30 | 2010-06-08 | Inotek Pharmaceuticals Corporation | Purine derivatives and methods of use thereof |
US9278991B2 (en) | 2012-01-26 | 2016-03-08 | Inotek Pharmaceuticals Corporation | Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof |
US9289383B2 (en) | 2010-03-26 | 2016-03-22 | Inotek Pharmaceuticals Corporation | Method of reducing intraocular pressure in humans |
US9370530B2 (en) | 2010-01-11 | 2016-06-21 | Inotek Pharmaceuticals Corporation | Combination, kit and method of reducing intraocular pressure |
US9522160B2 (en) | 2013-03-15 | 2016-12-20 | Inotek Pharmaceuticals Corporation | Ophthalmic formulations |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3595853A (en) * | 1968-03-19 | 1971-07-27 | Kohjin Co | Ribofuranosyl cytosine and arabinofuranosyl cytosine derivatives |
DE2105560A1 (en) * | 1971-02-06 | 1972-09-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Purine ribonucleoside derivatives and processes for making the same |
FR2152507A1 (en) * | 1971-09-10 | 1973-04-27 | Hoffmann La Roche |
-
1972
- 1972-05-30 DE DE19722226295 patent/DE2226295A1/en active Pending
-
1973
- 1973-04-18 AT AT346673A patent/AT323336B/en not_active IP Right Cessation
- 1973-05-24 FR FR7318902A patent/FR2186470A1/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3595853A (en) * | 1968-03-19 | 1971-07-27 | Kohjin Co | Ribofuranosyl cytosine and arabinofuranosyl cytosine derivatives |
DE2105560A1 (en) * | 1971-02-06 | 1972-09-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Purine ribonucleoside derivatives and processes for making the same |
FR2152507A1 (en) * | 1971-09-10 | 1973-04-27 | Hoffmann La Roche |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO339450B1 (en) * | 2004-05-26 | 2016-12-12 | Inotek Pharmaceuticals Corp | Purine derivatives such as adenosine A1 receptor agonists, preparations containing them and applications thereof |
EP1758596A4 (en) * | 2004-05-26 | 2007-08-01 | Inotek Pharmaceuticals Corp | Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
US7423144B2 (en) | 2004-05-26 | 2008-09-09 | Inotek Pharmaceuticals Corporation | Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof |
EP1758596A2 (en) * | 2004-05-26 | 2007-03-07 | Inotek Pharmaceuticals Corporation | Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
EP2221307A1 (en) * | 2004-05-26 | 2010-08-25 | Inotek Pharmaceuticals Corporation | Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
AU2005249430B2 (en) * | 2004-05-26 | 2011-06-23 | Inotek Pharmaceuticals Corporation | Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
US8183224B2 (en) | 2004-05-26 | 2012-05-22 | Inotek Pharmaceuticals Corporation | Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
US8609833B2 (en) | 2004-05-26 | 2013-12-17 | Inotek Pharmaceuticals Corporation | Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
US7732424B2 (en) | 2005-11-30 | 2010-06-08 | Inotek Pharmaceuticals Corporation | Purine derivatives and methods of use thereof |
US9370530B2 (en) | 2010-01-11 | 2016-06-21 | Inotek Pharmaceuticals Corporation | Combination, kit and method of reducing intraocular pressure |
US9289383B2 (en) | 2010-03-26 | 2016-03-22 | Inotek Pharmaceuticals Corporation | Method of reducing intraocular pressure in humans |
US9278991B2 (en) | 2012-01-26 | 2016-03-08 | Inotek Pharmaceuticals Corporation | Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof |
US9718853B2 (en) | 2012-01-26 | 2017-08-01 | Inotek Pharmaceuticals Corporation | Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-YL)-3,4-dihydroxytetrahydrofuran-2-YL)] methyl nitrate and processes of preparation thereof |
US9522160B2 (en) | 2013-03-15 | 2016-12-20 | Inotek Pharmaceuticals Corporation | Ophthalmic formulations |
Also Published As
Publication number | Publication date |
---|---|
AT323336B (en) | 1975-07-10 |
FR2186470B1 (en) | 1976-06-11 |
DE2226295A1 (en) | 1973-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT323181B (en) | PROCESS FOR THE PREPARATION OF NEW PYRROLO (3,4-B) PYRAZINE DERIVATIVES AND THEIR ACID ADDITION SALTS | |
SE425761B (en) | DEVICE FOR CARBON ACID TREATMENT OF Aqueous drinks | |
FR2186470A1 (en) | Purine nucleoside nitrates - for treating cardiac insufficiency | |
BG44537A3 (en) | Method for preparing of 2- amino- 3- ethoxycarbonylamino- 6- (p- fluor- benzylamino)- piridine gluconate | |
FR2110141A5 (en) | 2-thiazolyl-benzimidazoles prodn - from thiazole-4-carboxy- acid and ethylchloroformate with phenylenediamine via thiazolyl-carbo | |
FR2275209A1 (en) | Oxoalkyl esters of vincamine acids - and their pharm. acceptable salts for use in medicine | |
NZ180789A (en) | Production of nitrogrn-containing fertiliser by preparing nitrogen dioxide reacting it with water and using the nitric acid in preparing the fertiliser | |
NO149959C (en) | PROCEDURE FOR THE PREPARATION OF UREA BY THE REVERSION OF AMMONIAK WITH CARBON Dioxide | |
EG11878A (en) | Process for the absorption of ammonia in acid solution or slurries | |
FR2073343A1 (en) | 4-phenylamino-3-pyridine-sulphonic acids, diu - retics and antiinflammatories | |
ES392133A1 (en) | Manufacture of concentrated nitric acid | |
FR2170496A5 (en) | 7-Acylamino-3-substd.-3-cephem-4-carboxylic acids prepn. - from corresp. 7-(5-acylaminoadipamido) derivs | |
FR2073992A5 (en) | Substd oxadiazole insecticides | |
FR2166258A1 (en) | Calcium pangamate - for treatment of cardiovascular disorders | |
FR2277824A1 (en) | L-Pyrrolidone-5-carboxylic acid prodn using selective catalyst - by melt cyclisation of glutamic acid | |
FR2206324A1 (en) | 5-Fluoro-2,2'-cyclocytidine salts prodn. - by reacting corresp. cyclocyti-dine-salts with fluorine or hypofluorites in inert gas | |
FR2128115A1 (en) | Pyrid-3-ylmethyl aryloxy alkanoates - with lipotropic and coronary vasodilator activity | |
FR2178818A1 (en) | Phenylbutazone - aminoacid salts - anti-inflammatories and analgesics | |
IT1050706B (en) | 8-(2-Phenyl-ethyl)-1-oxa-3,8-diaza-spiro (4,5)-decan-2-one - prepd. by heating a related azide | |
CH558321A (en) | PROCESS FOR THE PRODUCTION OF CARBONIC ACIDS OR. CARBONIC ACID SALT. | |
FR1601063A (en) | Trimethoxybenzoyl-guanidines and their production | |
FR2213268A1 (en) | Nitro - aryl N,N,N',N' - tetrafluoro - diamine prepn. - from nitro - aryl carbonyl cpd. with difluoramine | |
FR2054955A5 (en) | Antimicrobial n-subst 6,7-methylenedioxy-4- - quinolone derivs prepn | |
JPS5256194A (en) | Process for copolyesterpolyol | |
FR2138498A1 (en) | Ampicillin alkyl sulphamic acid salts - prolonged release antibiotics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |